Scaffold-Free 3D ECM Models for Collagen Alignment Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current animal models for studying connective tissues and their diseases are expensive and have limited ability to recapitulate human pathophysiology, especially for conditions like Marfan Syndrome and Ehlers-Danlos syndrome, due to the challenge of developing mutation-specific genotype-phenotype correlations.
Innovation Solution
Development of in vitro 3D extracellular matrix (ECM) models that recapitulate the anisotropic architecture and mechanical phenotype of connective tissues, using a non-adhesive cell culture well with anchorage-dependent cells to synthesize ECM without external scaffolding, allowing for quantitative measurement of ECM properties and cellular alignment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal models are used to study connective tissues and diseases, then comprehensive in vivo data can be obtained, but the cost increases and the ability to recapitulate human pathophysiology is limited
Solution Approach 1:
The patent creates in vitro 3D tissue models that copy the essential structural and functional characteristics of native connective tissues. By replicating the ECM architecture, cell-ECM interactions, and mechanical properties in a controlled laboratory setting, the model provides human-specific pathophysiology data without requiring animal subjects. This copying approach enables direct human disease modeling while avoiding the translational gaps inherent in animal models.
Solution Approach 2:
The patent systematically varies key parameters including ECM composition (collagen type, concentration, crosslinking), architectural features (fibril alignment, porosity, density), and mechanical properties (stiffness, elasticity) to create disease-relevant phenotypes. By controlling these parameters in human-derived cells, the model can recapitulate specific human connective tissue disorders with precise genotype-phenotype correlations that are difficult to achieve in animal models.
2Stability of the object's composition
If in vitro 3D ECM models are developed without external scaffolding, then cell-driven self-assembly and native-like architecture are achieved, but the complexity of quantifying ECM properties increases
Solution Approach 1:
The patent replaces traditional mechanical testing approaches with advanced imaging and computational methods. Instead of using physical force application and measurement devices, the system uses multiphoton microscopy, second-harmonic generation imaging, and AI-based image analysis to quantify ECM architecture, collagen fibril organization, and tissue mechanics non-invasively. This substitution enables precise measurement of native-like ECM properties without disrupting the self-assembled structure.
Solution Approach 2:
The patent introduces computational algorithms and image processing intermediaries that bridge the gap between raw imaging data and quantitative ECM measurements. These computational tools automatically analyze complex 3D images, extract architectural parameters, and calculate mechanical properties from imaging data, thereby simplifying the overall measurement process while maintaining high precision in characterizing self-assembled ECM structures.
3Productivity
If anchorage-dependent cells are used to synthesize ECM without external scaffolding, then cell-mediated tissue formation is enhanced, but the difficulty of controlling and measuring cellular alignment increases
Solution Approach 1:
The patent creates localized microenvironments with specific ECM composition, stiffness, and architectural cues that guide cellular alignment in particular regions. By varying local ECM properties such as collagen fiber orientation, crosslinking density, and gel stiffness in different zones of the 3D construct, the model enables controlled cellular alignment patterns while maintaining high overall ECM synthesis productivity throughout the tissue.
Solution Approach 2:
The patent transitions from 2D monolayer cell culture to 3D tissue construction, adding spatial dimensions for cellular organization and ECM deposition. This 3D environment allows cells to align and synthesize ECM in multiple directions and planes, creating more physiologically relevant tissue architecture while enabling comprehensive measurement of alignment patterns through 3D imaging and computational analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides predictive models for human health and disease, enabling accurate quantification of ECM changes and tissue mechanics, suitable for applications in tissue engineering, genetic testing, drug testing, and drug discovery without relying on animal models.
Implementation Method 1
whereby the cells adhere to one another, exert cytoskeleton-mediated tension and/or cell-driven self-assembly to form a 3D ring-shaped geometry tissue ECM around the peg
Implementation Method 2
exert cytoskeleton-mediated tension and/or cell-driven self-assembly to form a 3D ring-shaped geometry tissue ECM around the peg
Data Source
AI summary
Described herein are in vitro quantitative methods directed to 3D extracellular matrix (ECM) organization and mechanics. The methods do not require application of an external force, anchorage, or a scaffolding material in order to culture ECM tissue constructs, and the methods enable quantitative measurements without crosstalk noise from variables attributable to external forces, anchorage, and scaffolding material.